Designing and generating a mouse model: frequently asked questionsChannabasavaiah B.Gurumurthy, Thomas L.Saunders, Masato Ohtsuka76-90
Harnessing CRISPR-Cas system diversity for gene editing technologiesAlexander McKay, Gaetan Burgio91-106
Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathiesJames B.Papizan, Shaina N.Porter, Akshay Sharma, Shondra M.Pruett-Miller115-134
Genome engineering technologies in rabbitsJun Song, Jifeng Zhang, Jie Xu, Minerva Garcia-Barrio, Y.Eugene Chen, Dongshan Yang135-147
Progress and challenges in CRISPR-mediated therapeutic genome editing for monogenic diseasesColin T.Konishi, Chengzu Long148-162
A transgenic pig model expressing a CMV-ZsGreen1 reporter across an extensive array of tissuesAmy T.Desaulniers, Rebecca A.Cederberg, Elizabeth P.Carreiro, Channabasavaiah B.Gurumurthy, Brett R.White163-173
Generating a CRISPR knockout mouse through a strong premature termination codon: a cautionary taleQing Rex Lyu, Peng Yao, Joseph M.Miano174-178
